Company Profile

Oculogica Inc
Profile last edited on: 3/14/2022      CAGE: 6YZ18      UEI: XE6ZBMCJ9LH5

Business Identifier: Eye-tracking based neurodiagnostics with primary focus on concussion
Year Founded
2013
First Award
2018
Latest Award
2018
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

33 Irving Place
New York, NY 10003
   (484) 393-2694
   N/A
   www.oculogica.com
Location: Single
Congr. District: 12
County: New York

Public Profile

Oculogica Inc. is a neurodiagnostic company developing patent-pending technology to detect brain abnormalities such as concussion and traumatic brain injury (TBI). The company's proprietary EyeBox technology* works by detecting patterns of abnormal eye movements and unlocks the potential to not only localize brain injury but also to assess its severity. With collaborators, the firm was founded by a neurosurgeon and research scientist. The firm's technology could transform traumatic brain injury diagnosis, bring personalized medicine to concussion diagnosis and treatment, and, most likely, for the military, on the playing field and court as well as in the hospital setting for those having inmany other ways incurred blows to their head, could improve outcomes for those millions of people who annually suffer TBI and concussion.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Rosina Samadani -- CEO and Board of Advisors

  Viridiana Juarez -- Analyst

  Christina Master

  Robert Ritlop -- Founder

  Hannah Rosenfeld -- Clinical Operations Manager

  Uzma Samadani -- Founder

  Daniel O Sanderson -- Principal Engineer

  Joel D Sanderson -- Developer

  Mark Stenoien -- VP of Regulatory Affairs

Company News